Hoese & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
WG
Hoese & Co's PFE Position: Q2 2026 in Review
Hoese & Co held its Pfizer (PFE) position steady in Q2 2026 at 5,000 shares worth $120K. The position accounts for 0.08% of the portfolio, ranked #72.
Hoese & Co first reported a position in PFE in Q4 2020 and has held it in 20 quarters since. The position peaked at $824K in Q4 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Hoese & Co held 5,000 shares of Pfizer worth $120K as of Q2 2026.
- Hoese & Co left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.08% of Hoese & Co's portfolio in Q2 2026, its #72 holding.
- Hoese & Co first reported a position in Pfizer in Q4 2020 and has held it in 20 quarters since.
- Hoese & Co's Pfizer position peaked at $824K in Q4 2021.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Hoese & Co's 13F filing for Q2 2026, filed 14 Jul 2026.